James McBrayer
Fortuna: 3 M $ al 31/05/2026
Fortuna: 3 M $ al 31/05/2026
James M.
McBrayer is currently the CEO, MD, Secretary & Executive Director at Cyclopharm Ltd. He started this position in 2014.
Prior to his current role, he served as the Chief Executive Officer at Lipa Pharmaceuticals Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CYCLOPHARM LIMITED 4,22 % | 12/03/2026 | 5.320.106 ( 4,22 % ) | 3 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CYCLOPHARM LIMITED | Director Ejecutivo | 21/10/2009 |
| Empresas | Cargo | Fin |
|---|---|---|
Lipa Pharmaceuticals Ltd.
Lipa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures complementary healthcare products | Director Ejecutivo | 13/08/2007 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Lipa Pharmaceuticals Ltd.
Lipa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures complementary healthcare products | Health Technology |
Cyclopharm Ltd.
Cyclopharm Ltd. Medical SpecialtiesHealth Technology Manufactures and sells medical health care equipments | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.